샘플 요청 목록

 카트 문의
시장보고서
상품코드
1882095

세계의 혈청학적 이식 진단 시장

Serological Transplant Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 161 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 혈청학적 이식 진단 시장은 2030년까지 20억 달러에 달할 전망

2024년에 12억 달러로 추정되는 세계의 혈청학적 이식 진단 시장은 2024-2030년의 분석 기간에 CAGR 8.6%로 성장하며, 2030년까지 20억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 시약·부속품은 9.2%의 CAGR을 기록하며, 분석 기간 종료까지 16억 달러에 달할 것으로 예측됩니다. 시스템 부문의 성장률은 분석 기간에 6.4%의 CAGR로 추정되고 있습니다.

미국 시장은 3억 2,510만 달러로 추정되는 한편, 중국은 12.1%의 CAGR로 성장할 것으로 예측됩니다.

미국에서 혈청학적 이식 진단 시장은 2024년에 3억 2,510만 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 12.1%로 추이하며, 2030년까지 4억 4,670만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역 시장으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 6.4%, 6.5%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 6.7%의 CAGR로 성장할 것으로 전망되고 있습니다.

세계의 혈청학적 이식 진단 시장 - 주요 동향과 촉진요인의 개요

이식 의료에서 혈청학적 진단이 중요한 이유

혈청학적 이식 진단은 이식 의료에서 매우 중요하며, 공여자와 수혜자의 적합성을 보장하고 이식편 거부반응을 예방하는 데 중요한 역할을 합니다. 이러한 진단에는 기증자와 수혜자 간의 면역학적 적합성을 평가하기 위한 인간 백혈구 항원(HLA) 항체 검사, 혈액형 검사, 교차 적합성 검사 등이 포함됩니다. 말기 장기 질환 증가로 인한 장기 이식 수요 증가는 이식 성공률과 환자 예후를 개선하기 위해 혈청학적 진단의 채택을 촉진하고 있습니다. 기증자 특이 항체(DSA) 및 기타 면역학적 마커의 조기 및 정확한 검출에 대한 중요성이 강조되면서 시장은 더욱 확대되고 있습니다. 이러한 검사는 임상의가 면역억제요법 및 이식 후 관리에 대한 정보에 입각한 판단을 내리는 데 도움이 될 수 있습니다.

기술 발전은 이식에서 혈청학적 진단을 어떻게 개선하고 있는가?

기술 혁신은 이식 혈청학적 진단 능력을 크게 향상시키고 정확성, 민감도, 자동화를 강화하고 있습니다. HLA 타이핑 및 교차 적합성 검사를 위한 자동화 플랫폼과 다중 분석의 개발로 검사 결과 보고 시간이 단축되어 이식 센터의 효율성이 향상되었습니다. 유세포분석, 루미넥스 기술, 차세대 염기서열 분석(NGS)의 활용으로 고해상도 HLA 타이핑이 가능해져 공여자와 수혜자의 적합성 향상과 이식 거부반응 위험 감소를 촉진하고 있습니다. 이식 진단에 AI 및 머신러닝 알고리즘을 통합하여 예측 분석 및 의사결정 지원 툴을 제공하여 임상의가 이식 환자를 보다 효과적으로 관리할 수 있도록 돕고 있습니다. 또한 비침습적 진단 툴와 세포 유리 DNA 검사의 발전은 이식편 거부반응 모니터링에 있으며, 유망한 접근법으로 부상하고 있으며, 침습적 생검의 필요성을 감소시키고 있습니다.

혈청학적 이식 진단의 채택을 주도하고 있는 시장 부문은 어디인가?

혈청학적 이식 진단 시장은 검사 유형, 응용 분야, 최종사용자, 지역별로 세분화됩니다. 검사 유형에는 HLA 타이핑, 교차 적합성 검사, 항체 스크리닝이 포함되며, 적합성 확보와 이식 거부반응률 감소에 중요한 역할을 하는 HLA 타이핑이 가장 널리 채택되고 있습니다. 적용 분야는 신장, 간, 심장, 폐, 기타 장기 이식에 걸쳐 있으며, 말기 신부전증의 높은 유병률과 생체 기증자의 가용성으로 인해 신장 이식이 가장 큰 부문으로 꼽히고 있습니다. 최종사용자로는 병원, 이식센터, 연구소, 진단검사기관 등이 있으며, 신속하고 정확한 진단 결과가 필요한 병원과 이식센터가 주요 개발처입니다. 지역별로는 첨단화된 의료 인프라와 높은 이식률을 바탕으로 북미와 유럽이 시장을 주도하고 있으며, 아시아태평양은 장기 이식 프로그램 증가와 의료비 지출 확대로 고성장 시장으로 부상하고 있습니다.

혈청학적 이식 진단 시장의 성장을 이끄는 주요 요인은?

혈청학적 이식 진단 시장의 성장은 장기 이식 수요 증가, 자동화 및 다중 진단 플랫폼의 발전, 면역학적 마커의 조기 및 정확한 검출에 대한 관심 증가 등 여러 요인에 의해 촉진되고 있습니다. 고해상도 HLA 타이핑, 항체 스크리닝, 교차 매칭 기술의 개발로 정밀하고 빠른 결과를 얻을 수 있게 되어 이식센터 및 병원에서 시장 도입이 진행되고 있습니다. 비침습적 진단과 개별화된 면역억제요법에 대한 관심이 높아지면서 이식 후 모니터링 및 환자 관리에 대한 시장 범위가 확대되고 있습니다. 첨단 혈청학적 진단을 통한 이식 성공률 향상과 이식편 거부반응 감소로의 전환은 시장 성장의 새로운 기회를 창출하고 있습니다. 또한 차세대 혈청학적 진단, AI 기반 예측 분석, 이식 거부반응 모니터링을 위한 무세포 DNA 검사에 대한 R&D 투자 증가는 시장 확대를 더욱 지원하고 있습니다.

부문:

제품 유형(시약·부속품, 시스템), 용도(신장 이식, 간 이식, 심장이식, 폐이식, 기타 용도), 최종 용도(병원, 혈액은행, 이식 센터, 기타 최종 용도)

조사 대상 기업의 예

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson &Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy S.A.S.
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업별 SLM을 쿼리하는 일반적인 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업 데이터, 제품/서비스 데이터, 시장 데이터 등이 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁 변화를 예측하면서 지역적 시장에 대한 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.12.11

Global Serological Transplant Diagnostics Market to Reach US$2.0 Billion by 2030

The global market for Serological Transplant Diagnostics estimated at US$1.2 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. Reagents & Accessories, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Systems segment is estimated at 6.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$325.1 Million While China is Forecast to Grow at 12.1% CAGR

The Serological Transplant Diagnostics market in the U.S. is estimated at US$325.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$446.7 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 6.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.7% CAGR.

Global Serological Transplant Diagnostics Market - Key Trends and Drivers Summarized

Why Are Serological Diagnostics Critical in Transplant Medicine?

Serological transplant diagnostics are crucial in transplant medicine, playing a vital role in ensuring donor-recipient compatibility and preventing graft rejection. These diagnostics involve testing for human leukocyte antigen (HLA) antibodies, blood typing, and crossmatching to assess the immunological compatibility between donors and recipients. The rising demand for organ transplants, driven by increasing cases of end-stage organ diseases, is fueling the adoption of serological diagnostics to improve transplant success rates and patient outcomes. The emphasis on early and accurate detection of donor-specific antibodies (DSAs) and other immunological markers is further driving the market, as these tests help clinicians make informed decisions on immunosuppressive therapies and post-transplant care.

How Are Technological Advancements Enhancing Serological Diagnostics in Transplants?

Technological advancements are significantly enhancing the capabilities of serological diagnostics in transplants, making them more accurate, sensitive, and automated. The development of automated platforms and multiplex assays for HLA typing and crossmatching is reducing turnaround times and improving the efficiency of transplant centers. The use of flow cytometry, Luminex technology, and next-generation sequencing (NGS) is enabling high-resolution HLA typing, facilitating better donor-recipient matching and minimizing the risk of graft rejection. The integration of AI and machine learning algorithms in transplant diagnostics is providing predictive analytics and decision support tools, helping clinicians manage transplant patients more effectively. Additionally, advancements in non-invasive diagnostic tools and cell-free DNA testing are emerging as promising approaches for monitoring allograft rejection, reducing the need for invasive biopsies.

Which Market Segments Are Leading the Adoption of Serological Transplant Diagnostics?

The serological transplant diagnostics market is segmented by test type, application, end-user, and region. Test types include HLA typing, crossmatching, and antibody screening, with HLA typing being the most widely adopted due to its critical role in ensuring compatibility and reducing transplant rejection rates. Applications span kidney, liver, heart, lung, and other organ transplants, with kidney transplants being the largest segment due to the high prevalence of end-stage renal disease and the availability of living donors. End-users include hospitals, transplant centers, research laboratories, and diagnostic laboratories, with hospitals and transplant centers being the primary adopters due to the need for rapid and accurate diagnostic results. Geographically, North America and Europe lead the market for serological transplant diagnostics due to advanced healthcare infrastructure and high transplant rates, while Asia-Pacific is emerging as a high-growth market driven by increasing organ transplantation programs and rising healthcare expenditure.

What Are the Key Drivers of Growth in the Serological Transplant Diagnostics Market?

The growth in the serological transplant diagnostics market is driven by several factors, including the increasing demand for organ transplants, advancements in automated and multiplex diagnostic platforms, and the rising focus on early and accurate detection of immunological markers. The development of high-resolution HLA typing, antibody screening, and crossmatching technologies that provide precise and rapid results is driving market adoption among transplant centers and hospitals. The growing emphasis on non-invasive diagnostics and personalized immunosuppressive therapies is expanding the market reach in post-transplant monitoring and patient management. The shift towards improving transplant success rates and reducing graft rejection through advanced serological diagnostics is creating new opportunities for market growth. Additionally, the increasing investments in R&D for next-generation serological diagnostics, AI-driven predictive analytics, and cell-free DNA testing for transplant rejection monitoring are further supporting market expansion.

SCOPE OF STUDY:

The report analyzes the Serological Transplant Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reagents & Accessories, Systems); Application (Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation, Other Applications); End-Use (Hospitals, Blood Banks, Transplant Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 18 Featured) -

  • Agena Bioscience, Inc.
  • Avioq, Inc.
  • Bag Health Care GmbH
  • Beckman Coulter, Inc.
  • Becton, Dickinson & Company
  • Biocell Medicare
  • Biogenuix Medsystems Pvt. Ltd.
  • Bio-Rad Laboratories, Inc.
  • DIAGAST
  • Grifols SA
  • Hemo bioscience, Inc.
  • Immucor, Inc.
  • Institut de Biotechnologies Jacques Boy S.A.S.
  • Lorne Laboratories Ltd.
  • MTC med. Produkte GmbH
  • Ortho Clinical Diagnostics
  • Quotient Biodiagnostics
  • REAGENS Kft.
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Tulip Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Serological Transplant Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Accurate and Reliable Transplant Compatibility Testing Drives Market for Serological Transplant Diagnostics
    • Technological Advancements in HLA Typing and Crossmatching Propel Innovation in Serological Diagnostics
    • Increasing Use of Serological Diagnostics in Kidney, Liver, Heart, and Lung Transplantation Expands Addressable Market Opportunity
    • Growth of Organ Transplantation Programs and Registries Strengthens Business Case for Serological Diagnostics
    • Challenges Related to Limited Availability of Donors and Ethical Issues Pose Market Constraints
    • Focus on Enhancing Sensitivity, Specificity, and Turnaround Time of Serological Tests Drives Market Adoption
    • Emergence of Automated and High-Throughput Serological Testing Platforms Generates New Market Opportunities
    • Rising Demand for Non-Invasive and Minimally Invasive Transplant Diagnostics Boosts Market Potential
    • Shift Towards Personalized Transplant Medicine and Immunogenetics Expands Market Reach
    • Growing Emphasis on Allograft Rejection Monitoring and Post-Transplant Care Spurs Market Innovation
    • Emergence of Serological Diagnostics as a Key Tool for Reducing Graft Rejection Rates Expands Adoption
    • Rising Number of Transplant Centers and Organ Sharing Networks Creates New Opportunities for Serological Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Serological Transplant Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Serological Transplant Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Kidney Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Liver Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Heart Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lung Transplantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Transplant Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Transplant Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Serological Transplant Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Serological Transplant Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Serological Transplant Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Serological Transplant Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Serological Transplant Diagnostics by Product Type - Reagents & Accessories and Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Serological Transplant Diagnostics by Product Type - Percentage Breakdown of Value Sales for Reagents & Accessories and Systems for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Serological Transplant Diagnostics by Application - Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Serological Transplant Diagnostics by Application - Percentage Breakdown of Value Sales for Kidney Transplantation, Liver Transplantation, Heart Transplantation, Lung Transplantation and Other Applications for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Serological Transplant Diagnostics by End-Use - Hospitals, Blood Banks, Transplant Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Serological Transplant Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals, Blood Banks, Transplant Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제